Search
for
Sort by
Research 631–660 of 1000+
- New onset alopecia and hirsutism in a postmenopausal women
- Recent advances in the treatment of polycystic ovary syndrome
- Clinical review 74: Dermatological manifestations of endocrine disorders.
- HIRSUTISM
- Cross‐sectional study of the prevalence of polycystic ovary syndrome in rural and urban populations
- Prevalence and Clinical Predictors of Insulin Resistance in Reproductive-Aged Thai Women with Polycystic Ovary Syndrome
- Steroid 17-Hydroxyprogesterone in Hair Is a Potential Long-Term Biomarker of Androgen Control in Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
- Polycystic ovary syndrome
- Androgen excess and post-reproductive health
- Infantile generalized hypertrichosis caused by topical minoxidil
- Polycystic Ovary Syndrome: Features, Diagnostic Criteria and Treatments
- Dermatologische Probleme bei Kindern mit Adipositas
- Polycystic ovary syndrome and acne.
- Polycystic Ovary Syndrome
- Choice of treatment for women with polycystic ovary syndrome
- Polycystic Ovary Syndrome and Reproductive Health: A Comprehensive Review
- Clinical and laboratory indicators of polycystic ovary syndrome in Chinese Han nationality with different Rotterdam criteria-based phenotypes
- Management of acne vulgaris with hormonal therapies in adult female patients
- Polycystic ovary syndrome
- Contraception for Women with Polycystic Ovary Syndrome: Dealing with a Complex Condition
- Polycystic ovary syndrome in men
- Metabolic Effect at Six and Twelve Months of Cyproterone Acetate (2 mg) Combined with Ethinyl Estradiol (35 μg) in 31 Patients
- Diagnostic Challenges in Ovarian Hyperthecosis: Clinical Presentation with Subdiagnostic Testosterone Levels
- Rodent models in placental research. Implications for fetal origins of adult disease
- The diagnosis of androgenetic alopecia in children: Considerations of pathophysiological plausibility
- LC-MS/MS improves screening towards 21-hydroxylase deficiency
- Obesity and female androgenic alopecia: A cause and an effect?
- Die Behandlung androgenisierter Frauen mit intramuskulär applizierbarem Cyproteronacetat
- Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome
- Prostate specific antigen (PSA) in diagnosis of polycystic ovarian syndrome – a new insight